The full arc of a listing in one place: the mega-IPO pipeline while it's still private, the calendar and debut performance when it lists, and the flow events — lockup expiries, greenshoe windows, index fast-entry dates — that actually move new listings afterward.
Every new listing on one board — the live QuantLogix 5-factor signal, debut return vs. offer, private-company DD when matched (readiness · filing · valuation), and the next flow event that moves it (lockup, greenshoe, index fast-entry). ⭐ a name to track it and get alerted on any headline.
How new public companies are actually doing: the live pipeline by stage, every recent IPO placed by its return since the offer, whether the Day-1 pop held, and each listing at every checkpoint. Click any mark for the company page.
| IPO | Day 1 | 1 month | 3 months | 6 months | 1 year | Today |
|---|---|---|---|---|---|---|
| Recent listings | ||||||
| LYCA2026-10 | +67% | · | · | · | · | +60% |
| DAVI2026-10 | -5% | · | · | · | · | -67% |
| CTY2026-10 | +24% | · | · | · | · | +16% |
| IAM2026-10 | +18% | · | · | · | · | -10% |
| AMRO2026-10 | +4% | · | · | · | · | +26% |
| RTSN2026-10 | -12% | · | · | · | · | +19% |
| TRXB2026-10 | 0% | · | · | · | · | -1% |
| CHWM2026-10 | +18% | · | · | · | · | -8% |
| ACCV2026-09 | 0% | · | · | · | · | -28% |
| RZAI2026-09 | -21% | · | · | · | · | -62% |
| ADRX2026-09 | +14% | +5% | · | · | · | +5% |
| ETRA2026-09 | -12% | -43% | · | · | · | -44% |
| OIG2026-09 | -3% | -18% | · | · | · | -24% |
| TRBG2026-09 | +10% | -65% | · | · | · | -68% |
| Seasoned IPOs — six months or more of trading | ||||||
| CHYM2025-06 | -14% | -29% | -45% | -36% | -59% | -34% |
| RDDT2024-03 | +7% | -11% | +22% | +41% | +167% | +195% |
| HOOD2021-07 | -8% | +23% | -7% | -69% | -76% | +144% |
| COIN2021-04 | -14% | -30% | -40% | -35% | -61% | -58% |
| ABNB2020-12 | -1% | +10% | +44% | +2% | +24% | +17% |
| PLTR2020-09 | -5% | +8% | +151% | +131% | +140% | +1888% |
| U2020-09 | -10% | +18% | +100% | +33% | +69% | -47% |
| SNOW2020-09 | +4% | -2% | +34% | -12% | +32% | +37% |
Every tracked pre-IPO company, tiered by how real the listing is (prose statuses normalized): registration statements actually on file, listings the company has signaled, and the biggest names the market keeps pricing a debut into — each chip carries an IPO readiness band.
Exchange calendar joined to the private-company tracker when we can match the issuer — readiness band, filing stage, and valuation chip link straight into the DD profile.
Most pending deals have no date until they price, so the undated ones are placed by simulation: 4,000 draws per deal from the announce→list lag of 29 recent listings (median 28 days, middle half 21–48), keeping only lags longer than the time each deal has already been pending. Seeded and reproducible. Confirmed dates are never simulated. 1 long-stalled filing (pending longer than nearly every deal in the sample) left off rather than forced into a week. A model of past timing, not a forecast of exchange dates.
Every company that graduated from the private tracker to a listing, plus the calendar's recent debuts — how each one traded from its IPO date to today, which regime it is in now, and the checkpoints in between. Built daily · as of 2026-10-27.
Log scale, so a +300% winner and a −75% broken issue share the frame; dashed line = offer price. Thick labelled lines are the 11 companies that graduated from the private tracker, thin lines are recent calendar debuts. Split-adjusted daily closes; direct listings with no offer are indexed to their first open. Hover a line for the numbers.
Regimes are rules, not a fitted model: day 1 ≥ +10% is a pop; a pop that still holds half its gain is Pop & hold, otherwise Pop & fade; a quiet debut that is now ≥ +20% is a Late bloomer, ≤ −20% a Broken issue, anything between Range-bound. Both axes are log-scaled price multiples. SPAC shells and listed funds excluded.
| Ticker | Company | Listed | Basis | Day 1 | 1M | 3M | 6M | 1Y | Since IPO | Max DD | Regime |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LYCA | Lycia Therapeutics, Inc. | 2026-10-23 | $18 | +66.7% | not yet | not yet | not yet | not yet | +60.3% | −3.8% | Pop & hold |
| DAVI | DAVION HEALTHCARE PLC | 2026-10-22 | first open $12.25 | −4.9% | not yet | not yet | not yet | not yet | −66.8% | −65.1% | Broken issue |
| CTY | CITY THERAPEUTICS, INC. | 2026-10-16 | $18 | +24.4% | not yet | not yet | not yet | not yet | +15.5% | −8.8% | Pop & hold |
| IAM | Iambic Therapeutics, Inc. | 2026-10-15 | $16 | +18.2% | not yet | not yet | not yet | not yet | −9.9% | −40.1% | Pop & fade |
| AMRO | Amaero Inc. | 2026-10-15 | $4.25 | +3.8% | not yet | not yet | not yet | not yet | +26.4% | −15.3% | Late bloomer |
| RTSN | Retension Pharmaceuticals, Inc. | 2026-10-09 | $12 | −12.3% | not yet | not yet | not yet | not yet | +18.7% | −12.8% | Range-bound |
| TRXB | TRex Bio, Inc. | 2026-10-09 | $14 | 0.0% | not yet | not yet | not yet | not yet | −0.9% | −10.9% | Range-bound |
| CHWM | Chilwa Minerals Ltd | 2026-10-01 | $5.6 | +17.9% | not yet | not yet | not yet | not yet | −8.4% | −29.5% | Pop & fade |
| ACCV | Accelevation Holdings Corp. | 2026-09-30 | $18 | −0.3% | not yet | not yet | not yet | not yet | −27.5% | −31.8% | Broken issue |
| RZAI | ROZE AI INC. | 2026-09-29 | first open $27.63 | −20.8% | not yet | not yet | not yet | not yet | −61.9% | −64.0% | Broken issue |
| ADRX | ADARx Pharmaceuticals, Inc. | 2026-09-25 | $17 | +13.8% | +4.8% | not yet | not yet | not yet | +4.8% | −17.0% | Pop & fade |
| ETRA | Electra Therapeutics, Inc. | 2026-09-18 | $15 | −11.7% | −42.6% | not yet | not yet | not yet | −44.2% | −39.9% | Broken issue |
| OIG | Orion180 Insurance Group Inc. | 2026-09-18 | $12 | −2.8% | −18.0% | not yet | not yet | not yet | −23.8% | −30.4% | Broken issue |
| TRBG | Turbogen Ltd. | 2026-09-03 | first open $10.79 | +9.7% | −64.8% | not yet | not yet | not yet | −68.2% | −72.6% | Broken issue |
| ADBT | Advasa Holdings, Inc. | 2026-08-25 | first open $12 | −47.8% | −99.0% | not yet | not yet | not yet | −99.0% | −98.5% | Broken issue |
| FBDT | First Breach, Inc. | 2026-08-20 | first open $12 | −65.4% | −92.6% | not yet | not yet | not yet | −93.1% | −84.6% | Broken issue |
| LYNX | Lyntris Inc. | 2026-08-19 | $17.5 | −14.2% | −21.8% | not yet | not yet | not yet | −38.8% | −34.6% | Broken issue |
| SNSC | SunScout Holding Ltd | 2026-08-12 | $5 | −38.6% | −77.2% | not yet | not yet | not yet | −84.9% | −75.5% | Broken issue |
| VOGX | Vogenx, Inc. | 2026-08-12 | $13 | 0.0% | +151.6% | not yet | not yet | not yet | +33.4% | −57.4% | Late bloomer |
| FOIL | Londian Wason New Energy Tech Inc. | 2026-08-12 | $22 | +11.4% | −6.0% | not yet | not yet | not yet | −23.1% | −33.8% | Pop & fade |
| LTGO | Latigo Biotherapeutics, Inc. | 2026-08-07 | $18 | +1.4% | +31.8% | not yet | not yet | not yet | −15.2% | −44.0% | Range-bound |
| TP | Ticketplus Ltd. | 2026-08-07 | $8 | −12.5% | +12.5% | not yet | not yet | not yet | +7.5% | −26.7% | Range-bound |
| BLSM | BlossomHill Therapeutics, Inc. | 2026-08-07 | $16 | 0.0% | +43.3% | not yet | not yet | not yet | +2.4% | −48.0% | Range-bound |
| BRVE | Braveheart Bio, Inc. | 2026-08-06 | $18 | +65.6% | +48.6% | not yet | not yet | not yet | +21.5% | −38.1% | Pop & fade |
| ATTO | Attovia Therapeutics, Inc. | 2026-08-05 | $17 | +28.8% | +42.4% | not yet | not yet | not yet | −18.4% | −46.3% | Pop & fade |
| APMD | Apnimed, Inc. | 2026-07-31 | $16 | +56.3% | +64.1% | not yet | not yet | not yet | +18.4% | −49.0% | Pop & fade |
| JMKE | Jersey Mike's Subs Inc. | 2026-07-30 | $23 | −6.0% | −2.3% | not yet | not yet | not yet | −26.5% | −34.2% | Broken issue |
| REF | Reformation Inc. | 2026-07-30 | $15 | +0.5% | 0.0% | not yet | not yet | not yet | +5.7% | −28.5% | Range-bound |
| GYGY | Game Your Game Inc. | 2026-07-30 | first open $22.5 | −29.0% | −94.8% | not yet | not yet | not yet | −98.6% | −98.0% | Broken issue |
| BSP🎓 | Bending Spoons | 2026-07-01 | $29 | +39.7% | +21.4% | +14.9% | not yet | not yet | +60.8% | −40.1% | Pop & hold |
| SPCX🎓 | SpaceX | 2026-06-12 | $135 | +19.2% | +0.2% | +9.7% | not yet | not yet | +8.8% | −46.3% | Pop & fade |
| CBRS🎓 | Cerebras Systems | 2026-05-14 | $185 | +68.1% | +17.9% | +18.4% | not yet | not yet | −41.4% | −65.2% | Pop & fade |
| CHYM🎓 | Chime | 2025-06-12 | first open $43 | −13.7% | −29.2% | −45.0% | −36.1% | −59.0% | −33.6% | −55.7% | Broken issue |
| RDDT🎓 | 2024-03-21 | first open $47 | +7.3% | −10.6% | +21.9% | +40.8% | +166.9% | +194.6% | −61.4% | Late bloomer | |
| HOOD🎓 | Robinhood | 2021-07-29 | first open $38 | −8.4% | +23.3% | −6.7% | −69.4% | −76.2% | +144.3% | −90.2% | Late bloomer |
| COIN🎓 | Coinbase | 2021-04-14 | first open $381 | −13.8% | −30.4% | −39.6% | −34.6% | −60.7% | −58.1% | −90.9% | Broken issue |
| ABNB🎓 | Airbnb | 2020-12-10 | first open $146 | −0.9% | +10.1% | +43.8% | +2.2% | +23.6% | +17.2% | −62.0% | Range-bound |
| PLTR🎓 | Palantir | 2020-09-30 | first open $10 | −5.0% | +7.5% | +151.0% | +130.7% | +140.4% | +1888.4% | −84.6% | Late bloomer |
| U🎓 | Unity | 2020-09-18 | first open $75.5 | −9.5% | +18.3% | +100.4% | +32.9% | +69.0% | −46.6% | −93.1% | Broken issue |
| SNOW🎓 | Snowflake | 2020-09-16 | first open $245 | +3.6% | −1.6% | +34.1% | −11.6% | +32.0% | +36.7% | −73.0% | Late bloomer |
Recent debuts ranked by return since their offer price, each carrying the live QuantLogix 5-factor signal — so you can see which IPOs the engine actually rates a Buy today, not just which popped on day one. Refreshed weekly.
If you put the same dollars into each of the next N listings and they behaved like the recent tape, here is the spread of basket outcomes — resampled with replacement from the debuts' returns since offer. A simulation of the past, not a forecast: change the inputs and watch the tails.
Long-form pre-IPO research on the pipeline's biggest names — financials, valuation math, listing mechanics, and the bear case.
A lockup bars pre-IPO holders (insiders, employees, early funds) from selling for a set period after listing — typically 180 days. The expiry date is a scheduled supply event: a large block of shares becomes sellable at once, which is why new listings often trade weakly into and around the date.
An over-allotment option letting underwriters sell up to ~15% additional shares and stabilize the price for about 30 days after listing. While the window is open, the underwriters are a price-supporting presence; once it closes, that support ends.
Index providers can admit very large new listings on an accelerated schedule — FTSE Russell can add a qualifying IPO to the Russell 1000/3000 after five trading days, and Nasdaq can admit one to the Nasdaq-100 after fifteen. Entry forces every index-tracking fund to buy, creating scheduled, mandatory demand with a date on it.
Academic IPO research (notably Jay Ritter’s long-run dataset) finds first-day buyers systematically overpay: the average IPO pops on day one, then underperforms over the following years. Allocators instead trade the flow calendar — index-entry dates, greenshoe close, the first earnings prints, and the lockup expiry. QuantLogix is a research platform; this is educational context, not advice.
Calendar data from licensed market-data feeds; mega-IPO profiles and readiness bands from the QuantLogix pre-IPO tracker (calendar rows matched to private companies when identity, ticker, or name confidence is high); flow events hand-curated with estimates labeled est. until confirmed in filings. Debut performance compares the final offer price to the latest traded price. Educational market analysis, not investment advice. Verified track record →